Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
100%(6 trials)

Phase Distribution

Ph phase_3
5
71%
Ph phase_4
1
14%
Ph phase_2
1
14%

Phase Distribution

0

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
5(71.4%)
Phase 4Post-market surveillance
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(6)
Terminated(1)

Detailed Status

Completed6
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (14.3%)
Phase 35 (71.4%)
Phase 41 (14.3%)

Trials by Status

withdrawn114%
completed686%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_4

Xyrem and Brain Dopamine in Narcolepsy

NCT02637076
completedphase_3

A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy

NCT02221869
withdrawnphase_2

Xyrem for Treatment Refractory Insomnia Due to PTSD

NCT00330291
completedphase_3

Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.

NCT00423605
completedphase_3

A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

NCT00423813
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT02637076Phase 4

Xyrem and Brain Dopamine in Narcolepsy

Completed
NCT02221869Phase 3

A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy

Completed
NCT00330291Phase 2

Xyrem for Treatment Refractory Insomnia Due to PTSD

Withdrawn
NCT00423605Phase 3

Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.

Completed
NCT00423813Phase 3

A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

Completed
NCT00066170Phase 3

Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy

Completed
NCT00371137Phase 3

A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7